These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 10606174
41. Expression of p53 in oligodendrogliomas. Kros JM, Godschalk JJ, Krishnadath KK, Van Eden CG. J Pathol; 1993 Dec; 171(4):285-90. PubMed ID: 8158458 [Abstract] [Full Text] [Related]
42. p53 status has no prognostic significance in glioblastomas treated with radiotherapy. Baxendine-Jones J, Campbell I, Ellison D. Clin Neuropathol; 1997 Dec; 16(6):332-6. PubMed ID: 9401801 [Abstract] [Full Text] [Related]
43. Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas. Broholm H, Bols B, Heegaard S, Braendstrup O. Clin Neuropathol; 1999 Dec; 18(4):176-80. PubMed ID: 10442459 [Abstract] [Full Text] [Related]
44. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas. Schneider-Stock R, Ziegeler A, Haeckel C, Franke DS, Rys J, Roessner A. Clin Cancer Res; 1999 Oct; 5(10):2830-5. PubMed ID: 10537349 [Abstract] [Full Text] [Related]
46. Expression of the p53 protein in a spectrum of astrocytic tumours. Ellison DW, Gatter KC, Steart PV, Lane DP, Weller RO. J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544 [Abstract] [Full Text] [Related]
50. Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas. Hagel C, Laking G, Laas R, Scheil S, Jung R, Milde-Langosch K, Stavrou DK. Eur J Cancer; 1996 Dec; 32A(13):2242-8. PubMed ID: 9038605 [Abstract] [Full Text] [Related]
51. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma. Deininger MH, Weller M, Streffer J, Meyermann R. Cancer; 1999 Nov 01; 86(9):1832-9. PubMed ID: 10547558 [Abstract] [Full Text] [Related]
52. Immunohistochemical detection of p53 protein in tumours of the central nervous system. Kuchelmeister K, Elborg B, Gullotta F. Pathologica; 1995 Oct 01; 87(5):498-502. PubMed ID: 8868174 [Abstract] [Full Text] [Related]
55. [Central neurocytoma. Immunohistochemical study: MIB1, p53 and bcl-2. Report of 5 cases]. Uro-Coste E, Bousquet P, Arrue P, Delisle MB. Arch Anat Cytol Pathol; 1999 Oct 01; 47(1):13-8. PubMed ID: 10089678 [Abstract] [Full Text] [Related]
56. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. J Neurol Neurosurg Psychiatry; 1995 Oct 01; 59(4):413-9. PubMed ID: 7561922 [Abstract] [Full Text] [Related]
58. Apoptosis and p53 expression in human gliomas. Sipos L, Szegedi Z, Fedorcsák I, Afra D, Szende B. Pathol Oncol Res; 1998 Oct 01; 4(4):267-70. PubMed ID: 9887356 [Abstract] [Full Text] [Related]
59. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling. Kleinschmidt-DeMasters BK, Hashizumi TL, Sze CI, Lillehei KO, Shroyer AL, Shroyer KR. J Clin Pathol; 1998 Apr 01; 51(4):284-93. PubMed ID: 9659240 [Abstract] [Full Text] [Related]